A translational proof of concept study in humans on the primary research question whether
novel anti-human immunodeficiency virus (HIV) latency strategies, including a BAF inhibitor
and a histone deacetylase inhibitor, result in HIV reservoir reduction in HIV patients on
antiretroviral therapy.